Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Thomas Jefferson University
Massachusetts General Hospital
City of Hope Medical Center
Case Comprehensive Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Massachusetts General Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center